Yu-Chao Lin
About
Yu-Chao Lin is a scholar working on Epidemiology, Molecular Medicine and Critical Care and Intensive Care Medicine.
According to data from OpenAlex, Yu-Chao Lin has authored 27 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Molecular Medicine and 7 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Yu-Chao Lin's work include Antibiotic Resistance in Bacteria (9 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotic Use and Resistance (6 papers). Yu-Chao Lin is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotic Use and Resistance (6 papers). Yu-Chao Lin collaborates with scholars based in Taiwan, Hong Kong and Denmark. Yu-Chao Lin's co-authors include Shinn‐Jye Liang, Chuen‐Ming Shih, Chia‐Hung Chen, Lingyun Chen, Wei Chen, Yao-Ling Lee, Sheng‐Huei Wang, Chau‐Chyun Sheu, Chung‐Kan Peng and Kuang‐Yao Yang and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Critical Care.
In The Last Decade
Yu-Chao Lin
26 papers receiving 248 citations
Peers
Yu-Chao Lin
M. Badia Spain
Huang-Shen Lin Taiwan
Ye Zhang China
Maryann Shango United States
Junaid Habib Khan United States
Dalia Adukauskienė Lithuania
Zhe Yuan China
Michaël Thy France
Kévin Alexandre France
Mia Furebring Sweden
Citations per year, relative to Yu-Chao Lin Yu-Chao Lin (= 1×)
peers
M. Badia
Countries citing papers authored by Yu-Chao Lin
Since
Specialization
Citations
This map shows the geographic impact of Yu-Chao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Chao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Chao Lin more than expected).
Fields of papers citing papers by Yu-Chao Lin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yu-Chao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Chao Lin. The network helps show where Yu-Chao Lin may publish in the future.
Co-authorship network of co-authors of Yu-Chao Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Chao Lin. A scholar is included among the top collaborators of Yu-Chao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Chao Lin. Yu-Chao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fu, Yuchang, et al.. (2025). High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection. PubMed. 58(4). 422–428.
2.
Chen, Wei-Cheng, et al.. (2024). Reduced mortality with antimicrobial stewardship guided by BioFire FilmArray Blood Culture Identification 2 panel in critically ill patients with bloodstream infection: A retrospective propensity score-matched study. International Journal of Antimicrobial Agents. 64(4). 107300–107300.
3.
Lin, Chi‐Chen, Wei‐Chih Liao, Yu-Chao Lin, et al.. (2024). The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study. BMC Cancer. 24(1). 228–228.
4.
Chen, Chia‐Hung, et al.. (2024). Optimal first-line treatment for EGFR-mutated NSCLC: a comparative analysis of osimertinib and second-generation EGFR-TKIs. BMC Pulmonary Medicine. 24(1). 517–517.
5.
Lin, Yu-Chao, et al.. (2024). The real-world impact of the BioFire FilmArray blood culture identification 2 panel on antimicrobial stewardship among patients with bloodstream infections in intensive care units with a high burden of drug-resistant pathogens. Journal of Microbiology Immunology and Infection. 57(4). 580–593.
6.
Chen, Wei-Cheng, et al.. (2024). Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units. Journal of Microbiology Immunology and Infection. 57(3). 480–489.
7.
Lin, Yu-Chao, Chung‐Kan Peng, Ming-Cheng Chan, et al.. (2024). Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study. Infection. 53(1). 197–207.
8.
Lin, Yu-Chao, et al.. (2023). Method Development for Determination of Doripenem in Human Plasma via Capillary Electrophoresis Coupled with Field-Enhanced Sample Stacking and Sweeping. International Journal of Molecular Sciences. 24(18). 13751–13751.
9.
Lin, Yu-Chao, et al.. (2023). High mortality of patients with severe pneumonia caused by respiratory syncytial virus, August 2021–June 2023, Taiwan. Journal of Microbiology Immunology and Infection. 57(1). 184–188.
10.
Wang, Sheng‐Huei, Kuang‐Yao Yang, Chau‐Chyun Sheu, et al.. (2023). Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospective propensity score-matched study. International Journal of Antimicrobial Agents. 63(1). 107044–107044.
11.
Lin, Yu‐Hsuan, Yu-Chao Lin, Yu‐Yu Lin, et al.. (2023). SLC and MLC In-Memory-Approximate-Search Solutions in Commercial 48-layer and 96-layer 3D-NAND Flash Memories. 1–4.
12.
Peng, Chung‐Kan, Chau‐Chyun Sheu, Yu-Chao Lin, et al.. (2023). Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Journal of Microbiology Immunology and Infection. 56(4). 822–832.
13.
Lin, Yu-Chao, et al.. (2023). A novel cation-selective exhaustive injection and sweeping micellar electrokinetic chromatography method for the simultaneous determination of second-generation triazoles in human plasma. Microchemical Journal. 196. 109703–109703.
14.
Shen, Yi‐Cheng, et al.. (2023). Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trials. Journal of Global Antimicrobial Resistance. 34. 46–58.
15.
Wang, Sheng‐Huei, Kuang‐Yao Yang, Chau‐Chyun Sheu, et al.. (2023). The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study. Scientific Reports. 13(1). 140–140.
16.
Chen, Chih‐Yu, Kuang‐Yao Yang, Chung‐Kan Peng, et al.. (2022). Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study. Scientific Reports. 12(1). 7501–7501.
17.
Hu, Han-Wen, Wei-Chen Wang, Yung-Chun Lee, et al.. (2022). A 512Gb In-Memory-Computing 3D-NAND Flash Supporting Similar-Vector-Matching Operations on Edge-AI Devices. 2022 IEEE International Solid- State Circuits Conference (ISSCC). 138–140.
18.
Feng, Jia‐Yih, Chung‐Kan Peng, Chau‐Chyun Sheu, et al.. (2021). Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clinical Microbiology and Infection. 27(10). 1465–1473.
19.
Lin, Yu-Chao, Shinn‐Jye Liang, Yiheng Liu, et al.. (2011). Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatology International. 32(6). 1669–1673.
20.
Lee, Yao-Ling, Wei Chen, Lingyun Chen, et al.. (2009). Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. Journal of Critical Care. 25(1). 176.e7–176.e13.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M. Badia Breakdown of academic impact, for papers by Huang-Shen Lin Breakdown of academic impact, for papers by Ye Zhang Breakdown of academic impact, for papers by Maryann Shango Breakdown of academic impact, for papers by Junaid Habib Khan Breakdown of academic impact, for papers by Dalia Adukauskienė Breakdown of academic impact, for papers by Zhe Yuan Breakdown of academic impact, for papers by Michaël Thy Breakdown of academic impact, for papers by Kévin Alexandre Breakdown of academic impact, for papers by Mia Furebring